EdaƱo, Eufemia P.
HRN: 22-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/11/2023
06/17/2023
IV
4.5g Then 2.25g
Q8h
Cap Hr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes